The Clinical Significance of PCDH10 Promoter Methylation in Patients with Bladder Transitional Cell Carcinoma

Publisher： Karger

E-ISSN： 1423-0399|90|2|219-224

ISSN： 0042-1138

Source： Urologia Internationalis, Vol.90, Iss.2, 2012-11, pp. : 219-224

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Clinical Significance of T-Cadherin Tissue Expression in Patients with Bladder Transitional Cell Carcinoma

By  

Urologia Internationalis, Vol. 86, Iss. 3, 2011-01 ,pp. : 340-345

Karger

Access to resources Recommend Favorite

Exon 2 Methylation Inhibits hepaCAM Expression in Transitional Cell Carcinoma of the Bladder

By  

Urologia Internationalis, Vol. 85, Iss. 3, 2010-07 ,pp. : 347-354

Karger

Access to resources Recommend Favorite

The Prognostic Significance of Pathologic Stage T0 on Organ-Confined Bladder Transitional Cell Carcinoma following Radical Cystectomy

By  

Urologia Internationalis, Vol. 81, Iss. 4, 2008-12 ,pp. : 394-398

Karger

Access to resources Recommend Favorite

Radical Cystectomy for Transitional Cell Carcinoma of the Bladder: What Percentage of Patients Qualifies for Bladder Preservation Protocols?

By  

Current Urology, Vol. 1, Iss. 1, 2007-09 ,pp. : 24-27

Karger

Access to resources Recommend Favorite

Isolated Meningeal Recurrence of Transitional Cell Carcinoma of the Bladder

By  

Case Reports in Oncology, Vol. 3, Iss. 2, 2010-06 ,pp. : 171-175

Karger

Access to resources Recommend Favorite